UPDATE 3-FDA says unsure if Novartis MS pill caused deaths

WASHINGTON, May 14 (Reuters) - U.S. health regulators said
on Monday they could not definitively link Novartis AG's
multiple sclerosis pill Gilenya with the deaths of
people who took the drug.

tax breaks for donations